Core Viewpoint - The company held its second extraordinary general meeting of shareholders in 2025, where several key resolutions were passed, including the election of the 13th board of directors and the approval of various governance proposals [1][2]. Meeting Details - The meeting took place on September 24, 2025, at 16:00 Beijing time, with both on-site and online voting options available [3][5]. - A total of 109 shareholders attended, representing 106,710,475 shares, which is 27.7094% of the total voting shares [8]. Election Results - The following non-independent directors were elected for a three-year term: - Chai Hongliang [15] - Fu Zhanhui [18] - Yan Dongmei [21] - Yang Huaqing [24] - The following independent directors were also elected: - Hu Benyuan [27] - Guo Jinlong [29] - Liu Wenbin [31] Governance Changes - The company approved a resolution to change its registered address and amend the articles of association, with 98.6342% of the voting shares in favor [34]. - Several management system amendments were also approved, including updates to the rules governing shareholder meetings and board meetings [36][38]. Financial and Audit Matters - The shareholders approved the increase of expected daily related party transactions for 2025, with 93.9346% voting in favor [46]. - The appointment of the accounting firm for the 2025 fiscal year was also approved, with 98.5218% support [48]. Legal Compliance - The meeting was attended by legal representatives who confirmed that all procedures and resolutions complied with relevant laws and regulations, ensuring the validity of the meeting's outcomes [50].

Core Viewpoint - The recent shareholder meeting of Nanmo Biology (688265.SH) raised concerns in the market as several key proposals were not approved, indicating potential internal conflicts and governance issues within the company [1][3]. Shareholder Meeting Outcomes - On September 23, 2025, Nanmo Biology held its second extraordinary shareholder meeting, reviewing 11 proposals, of which 5 were rejected, including those related to the company's three-year development plan and management stability [1][4]. - Only one of the additional six temporary proposals put forth by the Shanghai Pudong State-owned Assets Supervision and Administration Commission was approved, specifically regarding the purchase of liability insurance for directors and senior management [4][5]. Shareholding Structure - The shareholding structure of Nanmo Biology has become more concentrated, with a new shareholder, Suzhou Haiwang Hezhong No. 1 Equity Investment Partnership, acquiring 8.68 million shares, representing 11.13% of the total share capital [1][2]. - Haiwang Hezhong and Shanghai Pudong New Industry Investment Co., which holds 7.37% of the shares, are acting in concert, collectively owning 18.50% of the company [2]. Board Composition - The newly elected board consists of 11 directors, with 6 non-independent directors nominated by the controlling shareholder, and 4 independent directors, including one nominated by Haiwang Hezhong [5]. - The board's composition reflects a division among major shareholders, with the controlling shareholder's camp not being entirely unified, as evidenced by the recent dissolution of the agreement between key figures Fei Jian and Wang Mingjun [3][5].

本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 特别提示： 其中，通过深圳证券交易所交易系统进行网络投票的具体时间为：2025年9月18日9:15－9:25、9:30－ 11:30和13:00－15:00；通过深圳证券交易所互联网投票系统投票的具体时间为：2025年9月18日9:15－ 15:00期间的任意时间。 2、会议召开地点 深圳市龙华区观盛二路5号捷顺科技中心A座2306会议室。 3、会议方式 现场记名投票、网络投票相结合的方式。 1、本次股东大会未出现否决议案的情形。 2、本次股东大会没有增加或变更提案的情况。 一、会议召开和出席情况 1、召开时间 （1）现场会议于2025年9月18日下午15:00开始； （2）网络投票时间： 6、本次会议的召集、召开符合有关法律、行政法规、部门规章、规范性文件和公司章程的规定。 7、出席本次会议的股东及股东授权委托代表共157人，代表公司发行在外有表决权股份343,257,078股， 占公司发行在外有表决权股份总数的53.6516%（注：截至本次股东大会股权登记日，公司已累计回购 部分社会公众股份3,650,000 ...

Group 1 - The company held its sixth temporary board meeting of the eighth board on September 10, 2025, with all six directors present, complying with legal and regulatory requirements [2][3]. - The board approved the proposal to amend the company's articles of association, eliminating the supervisory board and transferring its responsibilities to the audit committee under the board [3][39]. - The revised articles of association and governance documents will be submitted for shareholder approval [5][40]. Group 2 - The board approved multiple governance document amendments, including rules for shareholder meetings, board meetings, independent director work systems, and others, all requiring shareholder approval [6][8][11]. - The board proposed the election of three non-independent directors and three independent directors for the ninth board, with terms starting upon shareholder approval [16][21][24]. - The independent directors' remuneration was set at 60,000 yuan per year, subject to shareholder approval [26][27]. Group 3 - The board approved a proposal for expected related party transactions for 2025, which will also require shareholder approval [28][29]. - A second temporary shareholder meeting is scheduled for September 29, 2025, to review the proposals submitted by the board [30].

Meeting Overview - The shareholder meeting of Yifan Pharmaceutical Co., Ltd. was held on September 5, 2025, with both on-site and online voting options available [1][2] - A total of 305 shareholders and representatives participated, representing 523,447,918 shares, which is 43.0329% of the total voting shares [1] Voting Participation - Among the participants, 298 were small investors and authorized representatives, with 24,242,411 shares represented, accounting for 1.9930% of the total voting shares [2] Proposal Voting Results - The following proposals were approved during the meeting: Amendment of Company Articles - The proposal to amend the Articles of Association received 99.9397% approval, with 523,132,518 votes in favor [2] Amendment of Shareholder Meeting Rules - The proposal to amend the Rules of Procedure for Shareholder Meetings was approved with 98.2548% support, totaling 514,312,460 votes [3] Amendment of Board Meeting Rules - The proposal to amend the Rules of Procedure for Board Meetings was approved with 98.2528% support, totaling 514,302,460 votes [4] Amendment of Independent Director Work System - The proposal to amend the Independent Director Work System received 98.2537% approval, with 514,307,160 votes in favor [4] Amendment of Fund Management Measures - The proposal to amend the Fund Management Measures was approved with 98.2552% support, totaling 514,314,660 votes [5] Amendment of Related Party Transaction Decision-Making System - The proposal to amend the Related Party Transaction Decision-Making System received 98.2542% approval, with 514,309,760 votes in favor [6] Amendment of Investment Management System - The proposal to amend the Investment Management System was approved with 98.2539% support, totaling 514,307,960 votes [6] Amendment of Accountant Selection System - The proposal to amend the Accountant Selection System received 98.2544% approval, with 514,310,660 votes in favor [7] Adjustment of Independent Director Allowances - The proposal to adjust the allowances for independent directors was approved with 99.9303% support, totaling 523,083,218 votes [8] Election of Non-Independent Directors - The election of non-independent directors was approved with 97.2691% support, totaling 509,153,070 votes [8] Election of Independent Directors - The election of independent directors received 99.4032% approval, with 520,324,012 votes in favor [9] Legal Opinion - The meeting was witnessed by lawyers from Anhui Tianhe Law Firm, confirming that the meeting's procedures and resolutions complied with relevant laws and regulations [9]

Core Viewpoint - The company, Huayi Family Co., Ltd., has made significant governance changes by abolishing the supervisory board and revising various internal management systems to enhance operational efficiency and compliance with legal regulations [1][2][3]. Group 1: Governance Changes - The board of directors approved the cancellation of the supervisory board, transferring its powers to the audit committee of the board [1]. - The company will revise its articles of association and related governance documents to reflect these changes [1][2]. - The decision to abolish the supervisory board was made in accordance with the new Company Law and relevant regulations [1]. Group 2: Management System Revisions - The company has revised its external guarantee management system to align with legal requirements and its operational realities [2][3]. - The related party transaction decision-making system has also been updated to ensure compliance with the latest regulations [2][3]. - The fundraising management measures have been revised to improve governance and operational efficiency [3][4]. Group 3: Board of Directors Election - The company plans to elect a new board of directors, with a proposed composition of eight members, including three independent directors [5]. - The candidates for the eighth board of directors have been recommended and will be submitted for shareholder approval [5][6]. - The election is scheduled to take place during the second extraordinary general meeting of shareholders on September 22, 2025 [6]. Group 4: Additional Management Revisions - The company will revise several internal management systems to strengthen business management and governance [4]. - The revised systems include guidelines for various committees, internal audit procedures, and investor relations management [4].

Group 1 - The company is holding its second extraordinary general meeting of shareholders in 2025 to discuss various proposals, including the election of the second board of directors [1][15][16] - The meeting will take place on September 11, 2025, at 14:30 in Huai'an, Jiangsu Province, and will combine on-site and online voting methods [6][13] - The company aims to ensure the legal rights of all shareholders and maintain order during the meeting, with specific registration and voting procedures outlined [2][4][5] Group 2 - Proposal 1 involves changing the company's business scope and amending the articles of association, specifically removing certain hazardous chemical operations [6][7] - Proposal 2 outlines the profit distribution plan for the first half of 2025, with a net profit of approximately 27.8 million yuan and a proposed cash dividend of 1.00 yuan per 10 shares, totaling 8.8 million yuan [13][14] - Proposals 3 and 4 focus on the election of non-independent and independent directors for the second board, with specific candidates nominated and their qualifications verified [15][16]

Core Viewpoint - The company is holding its second extraordinary general meeting of shareholders in 2025 to elect the eighth board of directors, including both non-independent and independent directors [5][6][7] Group 1: Meeting Procedures - The company has established guidelines to ensure the rights of all shareholders and the orderly conduct of the meeting, in accordance with relevant laws and regulations [1] - Shareholders and their representatives must sign in at least half an hour before the meeting and present necessary identification documents [2] - The meeting will follow the agenda as notified, allowing shareholders to exercise their rights to speak, inquire, and vote [3][4] Group 2: Election of Directors - The first proposal involves the election of three non-independent directors: Jin Xiaotuan, Zheng Jing, and Wang Qin, for a term of three years [6] - The second proposal includes the election of three independent directors: Gu Xinjian, Wu Xueyou, and Xu Fang, also for a term of three years [7] - The independent director candidates have varying qualifications, with two already holding independent director qualification certificates, while one is in the process of obtaining necessary training [7]

Group 1 - The company is holding a shareholders' meeting to ensure the rights of all shareholders and maintain order and efficiency during the meeting [1][2] - Attendance verification will be conducted for shareholders and their representatives, and latecomers will not be allowed to participate in voting [2][3] - The meeting will include a combination of on-site and online voting methods, with specific voting times outlined [5][6] Group 2 - The agenda includes the proposal to cancel the supervisory board and amend the company's articles of association, transferring the supervisory responsibilities to the audit committee of the board [6][8] - The company plans to elect a new board of directors, with specific candidates nominated for non-independent and independent director positions [9][12] - The meeting will conclude with the announcement of voting results and the signing of meeting records [7][8]

Core Points - The company is holding its first extraordinary general meeting of shareholders in 2025 to discuss various proposals related to corporate governance and board elections [1][5][12] Group 1: Meeting Procedures - Shareholders and their proxies must arrive at the meeting venue half an hour before the start to complete registration and present necessary identification documents [2][4] - The meeting will follow a predetermined agenda, and shareholders have the right to speak, inquire, and vote [2][3] - Voting will be conducted through a combination of on-site and online methods, with results announced after counting [3][5] Group 2: Agenda Items - Proposal 1: Revision of the company's articles of association to enhance governance by abolishing the supervisory board and transferring its powers to the audit committee [6][8] - Proposal 2: Revision of the rules governing shareholder meetings to align with updated regulations [7][9] - Proposal 3: Revision of the rules governing board meetings to ensure compliance with legal standards [8][10] - Proposal 4: Revision of the director remuneration management system to improve governance [9][11] - Proposal 5: Revision of the related party transaction management system to protect investor rights [10][12] - Proposal 6: Revision of the external investment management system to mitigate investment risks [11][12] - Proposal 7: Revision of the external guarantee management system to ensure asset safety [11][12] - Proposal 8: Revision of the fundraising management system to enhance efficiency [12] - Proposal 9: Election of non-independent directors for the fourth board, with a total of 9 directors proposed [12][13] - Proposal 10: Election of independent directors for the fourth board, with 3 independent directors proposed [13][14]